Two experimental drugs given to patients with psoriasis can clear the skin condition’s characteristic thick, dry, red patches at unprecedented rates. The finding paves the way for the long-term clinical trials required for regulatory approval of the medications.
By toning down a key immune protein, the drugs wipe out many psoriasis plaques while showing few signs of side effects.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.